In addition, blocking necroptosis and/or apoptosis effectively improved renal function and tubular lesion in the early and intermediate stages of CKD of SNx rats (8 weeks after SNx surgery).The greatest therapeutic effect was observed when both mechanisms were inhibited by combination treatment with Nec-1 and zVAD. The gene discussed is PCSK1; the disease is chronic kidney disease.